Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Susan P. Perrine, MD
Researcher Professor of Pediatrics, Medicine, Pharmacology and Experimental Therapeutics
Boston University School of Medicine
72 E. Concord St Instructional (L)
Boston, Massachusetts, United States
Her research is dedicated to identifying targeted mechanisms and therapeutics that modulate endogenous genes to treat serious diseases, such as reactivating the genes for fetal globin to ameliorate sickle cell disease and beta thalassemia, through inhibiting specific repressors. With Dr. Douglas Faller, she is applying a therapeutic to induce viral EBV genes and then use anti-viral agents to destroy lymphomas in which EBV resides. She also works on mechanisms and therapies to correct blood cell deficiencies.
Research Interests: Translational targeted therapeutics, molecular mechanisms of globin gene expression, pharmaceutical development
Clinical Interests: Hemoglobinopathies, thalassemias, viral lymphomas, cytopenias
+myBinderRelated Content
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
The 2020 ASPHO Conference – CANCELEDMore than 1,200 pediatric hematology/onc...
-
Kenneth Ataga, MDDr. Ataga's clinical interest is in clas...
-
3 Tips about Sickle Cell Disease – Every emergency provider needs to knowChildren and adults with sickle cell dis...
-
Sickle Cell Disease Program at Children’s HealthThe Sickle Cell Disease Program at Child...
-
Red Cell Pain Management Service at St George’s HospitalPeople with sickle cell disease can ofte...
-
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
